Abstract
Enhanced expression of the epidermal growth factor receptor (EGFR) or its ligands, epidermal growth factor (EGF) and transforming growth factor alpha (TGF-α) can increase signalling via receptor-mediated pathways which may lead to excessive proliferation and cellular transformation. Such autocrine regulation of growth has been demonstrated for prostate cancer cell lines in culture but its role in prostate cancerin vivo has not been established. To assess the potential of such a mechanism, we have examined the pathway components in prostate carcinomas (CaP) in comparison with non-malignant benign prostatic hyperplasias (BPH). In the present study, we investigate the dosage, structure and expression of EGF, TGF-α and EGFR genes in a series of 34 human prostate samples and 3 prostate cancer cell lines. All of the samples contained transcripts from each of the genes. The expression of pre-pro-TGF-α mRNA and pre-pro-EGF mRNA were significantly higher in CaP (n=13) than BPH (n=21) specimens (p<0.05). The androgen-responsive prostatic carcinoma cell line, LNCaP, expressed high levels of EGF mRNA while the androgen-independent DU145 and PC-3 cell lines expressed high levels of TGF-α mRNA and EGFR mRNA. In general, overexpression of these mRNAs was not associated with amplification or detectable gene rearrangment; only DU145 cells demonstrated any alteration in these genes, with apparent amplification of the TGF-α gene. Relative to BPH, all prostate carcinomas and cell lines studied had elevated levels of mRNA for one or both mRNA coding for the ligands for EGFR. Thus enhanced expression of the ligands and co-expression of the EGF receptor are frequent events in human prostate tumors, consistent with the cell culture data supporting autocrine growth regulation via EGFR-mediated pathways.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Carpenter G: Receptors for epidermal growth factor and other polypeptide mitogens. Ann Rev Biochem 56: 881–914, 1987
Carpenter G, Cohen S: Epidermal growth factor. Ann Rev Biochem 48: 193–216, 1979
Winkler ME, O'Connor L, Winget M, Fendly B: Epidermal growth factor and transforming growth factor alpha bind differently to the epidermal growth factor receptor. Biochemistry 28: 6373–6378, 1989
Stoscheck CM, King LEJ: Role of epidermal growth factor in carcinogenesis. Cancer Res 46: 1030–1037, 1986
Clark AJ, Ishii S, Richert N, Merlino GT, Pastan I: Epidermal growth factor regulates the expression of its own receptor. Proc Natl Acad Sci USA 82: 8374–8378, 1985
Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullrich A, Schlessinger J, Waterfield MD: Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307: 521–527, 1984
Todaro GJ, Fryling C, Delarco JE: Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 77: 5258–5262, 1980
Mydlo JH, Michaeli J, Cordon Cardo C, Goldenberg AS, Heston WD, Fair WR: Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. Cancer Res 49: 3407–3411, 1989
Bennett C, Paterson IM, Corbishley CM, Luqmani YA: Expression of growth factor and epidermal growth factor receptor encoded transcripts in human gastric tissues. Cancer Res 49: 2104–2111, 1989
Yamamoto T, Kamata N, Kawano H, Shimizu S, Kuroki T, Toyoshima K, Rikimaru K, Nomura N, Ishizaki R, Pastan I et al.: High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res 46: 414–416, 1986
Filmus J, Pollak MN, Cailleau R, Buick RN: MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem Biophys Res Commun 128: 898–905, 1985
Yoshida K, Kyo E, Tsujino T, Sano T, Niimoto M, Tahara E: Expression of epidermal growth factor, transforming growth factor-alpha and their receptor genes in human gastric carcinomas; implication for autocrine growth. Jpn J Cancer Res 81: 43–51, 1990
Sporn MB, Roberts AB: Peptide growth factors are multifunctional. Nature 332: 217–219, 1988
Sporn MB, Roberts AB: Autocrine, paracrine and endocrine mechanisms of growth control. Cancer Surv 4: 627–632, 1985
Goustin AS, Leof EB, Shipley GD, Moses HL: Growth factors and cancer. Cancer Res 46: 1015–1029, 1986
Bruchovsky N, Wilson JD: The coversion of testosterone to 5a-androstan-17-ol-3-ne by rat prostatein vivo andin vitro. J Biol Chem 243: 2012–2021, 1968
Bruchovsky N, Wilson JD: The intranuclear binding of testosterone and 5-androstan-17-ol-3 one by rat prostate. J Biol Chem 243: 5953–5960, 1968
Wilson JD, George FW, Griffin JE: The hormonal control of sexual development. Science 211: 1278–1284, 1981
Bruchovsky N, Lesser B, Van Doorn E, Cravan S: Hormonal effects an cell proliferation in the rat prostate vitam. Horm 33: 61–100, 1975
Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y: The endocrinology and developmental biology of the prostate. Endocr Rev 8: 338–362, 1987
Gregory H, Willshire IR, Kavanagh JP, Blacklock NJ, Chowdury S, Richards RC: Urogastrone-epidermal growth factor concentrations in prostatic fluid of normal individuals and patients with benign prostatic hypertrophy. Clin Sci 70: 359–363, 1986
Elson SD, Browne CA, Thorburn GD: Identification of epidermal growth factor-like activity in human male reproductive tissues and fluids. J Clin Endocrinol Metab 58: 589–594, 1984
Shaikh N, Lai L, McLoughlin J, Clark D, Williams G: Quantitative analysis of epidermal growth factor in human benign prostatic hyperplasia and prostatic carcinoma and its prognostic significance. Anticancer Res 10: 873–874, 1990
Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH: Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 47: 707–712, 1987
Connolly JM, Rose DP: Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line. Prostate 15: 177–186, 1989
Connolly JM, Rose DP: Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line. Prostate 16: 209–218, 1990
Maddy SQ, Chisholm GD, Hawkins RA, Habib FK: Localization of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods. J Endocrinol 113: 147–153, 1987
Eaton CL, Davies P, Phillips ME: Growth factor involvement and oncogene expression in prostatic tumours. J Steroid Biochem 30: 341–345, 1988
Hofer DR, Sherwood ER, Bromberg WD, Mendelsohn J, Lee C, Kozlowski JM: Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha. Cancer Res 51: 2780–2785, 1991
Morris GL, Dodd JG: Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol 143: 1272–1274, 1990
Berns EM, de Boer W, Mulder E: Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP. Prostate 9: 247–259, 1986
Stone K, Mickey DD, Wunderli H, Mickey G, Paulson DF: Isolation of human prostate carcinoma cell line (DU145). Int J Cancer 21: 274–281, 1978
Kaighn NE, Narayna KS, Ohnuki K, Lechnert F, Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC3). Invest Urol 17: 6–23, 1979
Gleason DF: Histologic grading and clinical staging of prostatic cancer. In: M Tannenbaum (ed.) Urologic Pathology: The Prostate. Lea and Febiger, Philadelphia, 1977, pp 171–198
Sambrook J, Fritsch EF, Maniatis T: Molecular cloning a laboratory manual. Cold Spring Harbor Laboratory Press, New York, 1990
Aviv H, Leder P: Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci USA 67: 1408–1412, 1977
Wilding G, Valverius E, Knabbe C, Gelmann EP: Role of transforming growth factor-alpha in human prostate cancer cell growth. Prostate 15: 1–12, 1989
Connolly JM, Rose DP: Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. Prostate 19: 173–180, 1991
Murray JC, DeHaven CR, Bell GI: RFLPs for epidermal growth factor (EGF), a single copy sequence 4q25-4q27. Nucleic Acids Res 14: 5117–5121, 1986
Murphy LC, Tsuyuki D, Myal Y, Shiu RPC: Isolation and sequencing of a cDNA clone for a prolactin-inducible protein (PIP). J Biol Chem 262: 15236–15341, 1987
Di Fiore PP, Pierce JH, Fleming TP, Hazan R, Ullrich A, King CR, Schlessinger J, Aaronson SA: Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 51: 1063–1070, 1987
Watanabe S, Lazar E, Sporn MB: Transformation of normal rat kidney (NRK) cells by an infectious retrovirus carrying an synthetic rat type alpha transforming growth factor gene. Proc Natl Acad Sci USA 84: 1258–1262, 1987
Stern DF, Hare DL, Cecchini MA, Weinberg RA: Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor. Science 235: 321–324, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ching, K.Z., Ramsey, E., Pettigrew, N. et al. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 126, 151–158 (1993). https://doi.org/10.1007/BF00925693
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00925693